BTRC and nasopharyngeal carcinoma: According to our findings, in this study, we proposed βTrCP as a novel diagnostic biomarker for NPC, because the low expression of βTrCP was a poor prognostic factor in NPC, due to its down-regulation by EBV-miR-BART10-3p.